Shop picked for Viagra rival

Published on .

The next impotence product is likely to come from Schering-Plough Corp., Liberty Corner, N.J., which awarded its Vasomax direct-to-consumer prescription brand to Robert A. Becker Euro RSCG, New York. Though Vasomax awaits U.S. Food & Drug Administration approval, Schering is expected to spend competitively against Pfizer's Viagra, which is supported by a $35 million campaign from Cline Davis Mann, New York, that broke last month.

Copyright July 1998, Crain Communications Inc.

In this article:
Most Popular